StonvexLoading…
StonvexStonvexStonvexCore line items from LPTH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $37.20M | $31.73M | $32.93M | $35.56M |
Operating Income | $-11.82M | $-7.83M | $-3.55M | $-2.63M |
Net Income | $-14.87M | $-8.01M | $-4.05M | $-3.54M |
EPS (Diluted) | $-0.36 | $-0.21 | $-0.13 | $-0.13 |
Total Assets | $81.51M | $48.09M | $53.54M | $50.71M |
Total Liabilities | $31.63M | $17.89M | $17.58M | $20.98M |
Cash & Equivalents | $4.88M | $3.48M | $4.69M | $5.51M |
Free Cash Flow OCF − CapEx | $-9.59M | $-1.66M | $-5.89M | $-162.49K |
Shares Outstanding | 42.95M | 39.25M | 37.34M | 27.05M |